Replies to post #313381 on Amarin Corp Plc (AMRN)

[north40000]

#313381–Dr. Bhatt says, in his review of 2020 AHA Scientific Sessions, that having a composition capable of lowering trigs is not enough to establish that composition will reduce CVD risk as well. Now apply the video and transcript text to where H finds itself today. The composition in H’s capsule is not the same(identical) as the composition in Vascepa capsule; H has run no Reduce-It outcomes study on its composition within its capsule.